Hartmann B - Search Results

1

Virus-specific lymphokine production differs quantitatively but not qualitatively in acute and chronic hepatitis B infection.

Jung MC, Hartmann B, Gerlach JT, Diepolder H, Gruber R, Schraut W, Grüner N, Zachoval R, Hoffmann R, Santantonio T, Wächtler M, Pape GR. Jung MC, et al. Among authors: hartmann b. Virology. 1999 Sep 1;261(2):165-72. doi: 10.1006/viro.1999.9833. Virology. 1999. PMID: 10497102 Free article.

2

Biochemical monitoring of mTOR inhibitor-based immunosuppression following kidney transplantation: a novel approach for tailored immunosuppressive therapy.

Hartmann B, Schmid G, Graeb C, Bruns CJ, Fischereder M, Jauch KW, Heeschen C, Guba M. Hartmann B, et al. Kidney Int. 2005 Dec;68(6):2593-8. doi: 10.1111/j.1523-1755.2005.00731.x. Kidney Int. 2005. PMID: 16316335 Free article. Clinical Trial.

3

Therapeutic plasma exchange in the intensive care setting.

Samtleben W, Mistry-Burchardi N, Hartmann B, Lennertz A, Bosch T. Samtleben W, et al. Among authors: hartmann b. Ther Apher. 2001 Oct;5(5):351-7. doi: 10.1046/j.1526-0968.2001.00383.x. Ther Apher. 2001. PMID: 11778919 Review.

4

Development of a sensitive phospho-p70 S6 kinase ELISA to quantify mTOR proliferation signal inhibition.

Hartmann B, He X, Keller F, Fischereder M, Guba M, Schmid H. Hartmann B, et al. Ther Drug Monit. 2013 Apr;35(2):233-9. doi: 10.1097/FTD.0b013e3182804c9b. Ther Drug Monit. 2013. PMID: 23503450

5

p70S6 kinase phosphorylation for pharmacodynamic monitoring.

Hartmann B. Hartmann B. Clin Chim Acta. 2012 Sep 8;413(17-18):1387-90. doi: 10.1016/j.cca.2012.03.023. Epub 2012 Apr 13. Clin Chim Acta. 2012. PMID: 22531277 Review.

6

Safety and efficacy of everolimus after kidney and hematopoietic stem cell transplantation.

Keller F, Wiesner S, Bunjes D, Hartmann B, Schmitt M. Keller F, et al. Among authors: hartmann b. Ann Transplant. 2012 Dec 31;17(4):52-8. doi: 10.12659/aot.883694. Ann Transplant. 2012. PMID: 23274324

7

Biomarkers as a tool for management of immunosuppression in transplant patients.

Wieland E, Olbricht CJ, Süsal C, Gurragchaa P, Böhler T, Israeli M, Sommerer C, Budde K, Hartmann B, Shipkova M, Oellerich M. Wieland E, et al. Among authors: hartmann b. Ther Drug Monit. 2010 Oct;32(5):560-72. doi: 10.1097/FTD.0b013e3181efb3d2. Ther Drug Monit. 2010. PMID: 20814352 Review.

8

Critical evaluation of rituximab rescue in 27 patients with different types of kidney disease.

Ganzemueller J, Hartmann B, Keller F, Stracke S. Ganzemueller J, et al. Among authors: hartmann b. Minerva Urol Nefrol. 2011 Dec;63(4):263-72. Minerva Urol Nefrol. 2011. PMID: 21996981 Clinical Trial.

9

Performance of a phosphoflow assay to determine phosphorylation of S6 ribosomal protein as a pharmacodynamic read out for mTOR inhibition.

Abdel-Kahaar E, Kabakchiev M, Hartmann B, Wieland E, Shipkova M. Abdel-Kahaar E, et al. Among authors: hartmann b. Clin Biochem. 2016 Oct;49(15):1181-1187. doi: 10.1016/j.clinbiochem.2016.06.012. Epub 2016 Jun 29. Clin Biochem. 2016. PMID: 27372285

10

Review on pharmacokinetics and pharmacodynamics and the aging kidney.

Aymanns C, Keller F, Maus S, Hartmann B, Czock D. Aymanns C, et al. Among authors: hartmann b. Clin J Am Soc Nephrol. 2010 Feb;5(2):314-27. doi: 10.2215/CJN.03960609. Epub 2010 Jan 7. Clin J Am Soc Nephrol. 2010. PMID: 20056753 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

958 results

Search Page

Filters